TNFRSF10C
Basic information
Region (hg38): 8:23102921-23117445
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TNFRSF10C gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 11 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 6 | 6 | 2 |
Variants in TNFRSF10C
This is a list of pathogenic ClinVar variants found in the TNFRSF10C region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
8-23103164-G-T | Likely benign (May 04, 2018) | |||
8-23111721-T-A | not specified | Uncertain significance (May 07, 2024) | ||
8-23111736-C-A | not specified | Uncertain significance (Nov 10, 2023) | ||
8-23111747-C-T | not specified | Uncertain significance (Dec 19, 2022) | ||
8-23111769-A-C | not specified | Uncertain significance (Sep 01, 2021) | ||
8-23111803-C-A | not specified | Likely benign (Mar 07, 2023) | ||
8-23111807-G-A | not specified | Uncertain significance (Mar 19, 2024) | ||
8-23114662-C-G | not specified | Uncertain significance (Jul 19, 2023) | ||
8-23114694-G-A | Benign (Mar 05, 2018) | |||
8-23114707-G-T | not specified | Uncertain significance (Jul 17, 2023) | ||
8-23114715-C-T | Benign (Jul 06, 2018) | |||
8-23114722-G-A | not specified | Likely benign (Nov 03, 2022) | ||
8-23115599-G-A | not specified | Uncertain significance (Jul 20, 2021) | ||
8-23116718-A-G | not specified | Likely benign (May 24, 2023) | ||
8-23116765-C-T | Likely benign (Jul 01, 2022) | |||
8-23116857-G-C | Likely benign (Nov 01, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TNFRSF10C | protein_coding | protein_coding | ENST00000356864 | 5 | 33083 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00000316 | 0.196 | 125014 | 4 | 730 | 125748 | 0.00292 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.819 | 121 | 149 | 0.811 | 0.00000778 | 1677 |
Missense in Polyphen | 41 | 35.854 | 1.1435 | 427 | ||
Synonymous | 1.88 | 35 | 52.3 | 0.669 | 0.00000265 | 521 |
Loss of Function | -0.235 | 8 | 7.31 | 1.09 | 3.08e-7 | 91 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00287 | 0.00287 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.000832 | 0.000832 |
European (Non-Finnish) | 0.00546 | 0.00544 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000342 | 0.0000327 |
Other | 0.00310 | 0.00310 |
dbNSFP
Source:
- Function
- FUNCTION: Receptor for the cytotoxic ligand TRAIL. Lacks a cytoplasmic death domain and hence is not capable of inducing apoptosis. May protect cells against TRAIL mediated apoptosis by competing with TRAIL-R1 and R2 for binding to the ligand.;
- Pathway
- Influenza A - Homo sapiens (human);Necroptosis - Homo sapiens (human);Natural killer cell mediated cytotoxicity - Homo sapiens (human);Measles - Homo sapiens (human);Apoptosis - Homo sapiens (human);Cytokine-cytokine receptor interaction - Homo sapiens (human);Apoptosis Modulation and Signaling;TP53 Regulates Transcription of Cell Death Genes;VEGFA-VEGFR2 Signaling Pathway;Gene expression (Transcription);Generic Transcription Pathway;TP53 Regulates Transcription of Cell Death Genes;RNA Polymerase II Transcription;Transcriptional Regulation by TP53;Direct p53 effectors;TRAIL signaling pathway;TP53 Regulates Transcription of Death Receptors and Ligands
(Consensus)
Intolerance Scores
- loftool
- 0.605
- rvis_EVS
- 0.57
- rvis_percentile_EVS
- 81.99
Haploinsufficiency Scores
- pHI
- 0.0857
- hipred
- N
- hipred_score
- 0.112
- ghis
- 0.437
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.287
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Tnfrsf10b
- Phenotype
- cellular phenotype; homeostasis/metabolism phenotype; endocrine/exocrine gland phenotype; immune system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; neoplasm;
Gene ontology
- Biological process
- TRAIL-activated apoptotic signaling pathway;regulation of apoptotic process;positive regulation of apoptotic process
- Cellular component
- plasma membrane;cell surface;anchored component of membrane
- Molecular function
- transmembrane signaling receptor activity;TRAIL binding